Full Text
PCN32 COST-UTILITY ANALYSIS OF DOCETAXEL VERSUS OTHER REGIMENS IN THE NEOADJUVANT THERAPY OF LOCALLY ADVANCED BREAST CANCER IN POLAND

Abstract

Authors

J Walczak D Pawlik R Wojcik M Kaczor J Lis G Nogas

Back to Volume 10, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×